BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35588569)

  • 1. New twists to the ALTernative endings at telomeres.
    Bhargava R; Lynskey ML; O'Sullivan RJ
    DNA Repair (Amst); 2022 Jul; 115():103342. PubMed ID: 35588569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATRX/DAXX: Guarding the Genome against the Hazards of ALT.
    Clatterbuck Soper SF; Meltzer PS
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
    Lovejoy CA; Li W; Reisenweber S; Thongthip S; Bruno J; de Lange T; De S; Petrini JH; Sung PA; Jasin M; Rosenbluh J; Zwang Y; Weir BA; Hatton C; Ivanova E; Macconaill L; Hanna M; Hahn WC; Lue NF; Reddel RR; Jiao Y; Kinzler K; Vogelstein B; Papadopoulos N; Meeker AK;
    PLoS Genet; 2012; 8(7):e1002772. PubMed ID: 22829774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Lengthening of Telomeres and Chromatin Status.
    Udroiu I; Sgura A
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31905921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macroH2A1.2 histone variant links ATRX loss to alternative telomere lengthening.
    Kim J; Sun C; Tran AD; Chin PJ; Ruiz PD; Wang K; Gibbons RJ; Gamble MJ; Liu Y; Oberdoerffer P
    Nat Struct Mol Biol; 2019 Mar; 26(3):213-219. PubMed ID: 30833786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta.
    Novakovic B; Napier CE; Vryer R; Dimitriadis E; Manuelpillai U; Sharkey A; Craig JM; Reddel RR; Saffery R
    Mol Hum Reprod; 2016 Nov; 22(11):791-799. PubMed ID: 27604461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Loss of
    Graham MK; Kim J; Da J; Brosnan-Cashman JA; Rizzo A; Baena Del Valle JA; Chia L; Rubenstein M; Davis C; Zheng Q; Cope L; Considine M; Haffner MC; De Marzo AM; Meeker AK; Heaphy CM
    Mol Cancer Res; 2019 Dec; 17(12):2480-2491. PubMed ID: 31611308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization.
    Li F; Deng Z; Zhang L; Wu C; Jin Y; Hwang I; Vladimirova O; Xu L; Yang L; Lu B; Dheekollu J; Li JY; Feng H; Hu J; Vakoc CR; Ying H; Paik J; Lieberman PM; Zheng H
    EMBO J; 2019 Oct; 38(19):e96659. PubMed ID: 31454099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.
    Liu H; Xu C; Diplas BH; Brown A; Strickland LM; Yao H; Ling J; McLendon RE; Keir ST; Ashley DM; He Y; Waitkus MS
    Neuro Oncol; 2023 Sep; 25(9):1563-1575. PubMed ID: 36689342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
    Episkopou H; Draskovic I; Van Beneden A; Tilman G; Mattiussi M; Gobin M; Arnoult N; LondoƱo-Vallejo A; Decottignies A
    Nucleic Acids Res; 2014 Apr; 42(7):4391-405. PubMed ID: 24500201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).
    Falcinelli M; Dell'Omo G; Grassi E; Mariella E; Leto SM; Scardellato S; Lorenzato A; Arena S; Bertotti A; Trusolino L; Bardelli A; d'Adda di Fagagna F
    Cell Death Dis; 2023 Feb; 14(2):96. PubMed ID: 36759506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes.
    Min J; Wright WE; Shay JW
    Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XPF activates break-induced telomere synthesis.
    Guh CY; Shen HJ; Chen LW; Chiu PC; Liao IH; Lo CC; Chen Y; Hsieh YH; Chang TC; Yen CP; Chen YY; Chen TW; Chen LY; Wu CS; Egly JM; Chu HC
    Nat Commun; 2022 Oct; 13(1):5781. PubMed ID: 36184605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.
    Minasi S; Baldi C; Pietsch T; Donofrio V; Pollo B; Antonelli M; Massimino M; Giangaspero F; Buttarelli FR
    J Neurooncol; 2019 May; 142(3):435-444. PubMed ID: 30830680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere recombination and alternative telomere lengthening mechanisms.
    Draskovic I; Londono Vallejo A
    Front Biosci (Landmark Ed); 2013 Jan; 18(1):1-20. PubMed ID: 23276906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TERRA and RAD51AP1 promote alternative lengthening of telomeres through an R- to D-loop switch.
    Yadav T; Zhang JM; Ouyang J; Leung W; Simoneau A; Zou L
    Mol Cell; 2022 Nov; 82(21):3985-4000.e4. PubMed ID: 36265486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
    Arora R; Lee Y; Wischnewski H; Brun CM; Schwarz T; Azzalin CM
    Nat Commun; 2014 Oct; 5():5220. PubMed ID: 25330849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
    Clynes D; Jelinska C; Xella B; Ayyub H; Scott C; Mitson M; Taylor S; Higgs DR; Gibbons RJ
    Nat Commun; 2015 Jul; 6():7538. PubMed ID: 26143912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer.
    Mori JO; Keegan J; Flynn RL; Heaphy CM
    J Clin Pathol; 2024 Jan; 77(2):82-86. PubMed ID: 37890990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life and cancer without telomerase: ALT and other strategies for making sure ends (don't) meet.
    Apte MS; Cooper JP
    Crit Rev Biochem Mol Biol; 2017 Feb; 52(1):57-73. PubMed ID: 27892716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.